TRAD CHI MED(00570): Chen Kun appointed as a non-executive director and a member of the remuneration and assessment committee.
China Traditional Chinese Medicine (00570) announced that the board of directors made a resolution on May 15, 2026, and Mr. Liu Haijian has resigned as a non-executive director due to adjustments in job responsibilities, with immediate effect. After his resignation as a non-executive director takes effect, Mr. Liu will no longer serve as a member of the Board Remuneration and Assessment Committee. Mr. Chen Kun has been appointed as a non-executive director and a member of the Remuneration and Assessment Committee, effective from May 15, 2026.
TRAD CHI MED (00570) announced that the board of directors made a resolution on May 15, 2026, to accept the resignation of Mr. Liu Haijian as a non-executive director, due to job adjustments. The relevant arrangements take immediate effect. After resigning as a non-executive director, Mr. Liu will no longer serve as a member of the board's Remuneration and Evaluation Committee. Mr. Chen Kun has been appointed as a non-executive director and a member of the Remuneration and Evaluation Committee, effective from May 15, 2026.
Related Articles

XIAOMI-W (01810) spent HKD 99.9947 million on May 15 to repurchase 3.256 million shares.

Viva Biotech (01873) spent HKD 1.3825 million on May 15th to repurchase 955,000 shares.

TENFU (06868) spent HKD 8570 on May 15 to repurchase 3000 shares.
XIAOMI-W (01810) spent HKD 99.9947 million on May 15 to repurchase 3.256 million shares.

Viva Biotech (01873) spent HKD 1.3825 million on May 15th to repurchase 955,000 shares.

TENFU (06868) spent HKD 8570 on May 15 to repurchase 3000 shares.






